Protocol for a Randomized Controlled Trial Comparing Intravitreal Brolucizumab with Placebo for Chronic Central Serous Chorioretinopathy with Persistent Macular Fluid Without Choroidal Neovascular Membrane – BRICS Report #1

Seminars in Ophthalmology

Authors 0

1. Author list not loaded yet.